Strumento inattivo

Azioni Transition Therapeutics Inc

Azioni

Durata

Periodo

Stile

Transition Therapeutics : Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Arrangement with OPKO Health, Inc.	26/08/16
Transition Therapeutics : Receives Notification From NASDAQ	03/06/16
Transition Therapeutics : Announces Third Quarter Fiscal 2016 Financial Results	11/05/16
Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2016 Financial Results on Wednesday, May 11th, at 4:30 P.M. EST	09/05/16
Transition Therapeutics : Provides Update on Type 2 Diabetes Drug Candidate TT401	18/04/16

Dirigenti	Titolo	Età	Da
Antonio F. Cruz CEO	Chief Executive Officer	71	06/07/98

Amministratori	Titolo	Età	Da
Antonio F. Cruz CEO	Chief Executive Officer	71	06/07/98

Settore

	Variaz. 1 gen.	Capi.
CSL LIMITED	-4,66%	86,13 Mrd
SAMSUNG BIOLOGICS CO.,LTD.	+1,32%	39,82 Mrd
BIOGEN INC.	-19,27%	30,42 Mrd
UCB	+57,86%	25,23 Mrd
INCYTE CORPORATION	-17,69%	11,6 Mrd
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,00%	11,51 Mrd
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,14%	11,95 Mrd
SWEDISH ORPHAN BIOVITRUM AB	+5,24%	8,71 Mrd
INNOVENT BIOLOGICS, INC.	-8,42%	8,12 Mrd